Wyoming SF19: Epinephrine delivery methods.

What the bill says

An act relating to public health and safety; authorizing the administration of epinephrine through the use of autoinjectors, nasal sprays and any other federally approved device or method; amending definitions; requiring rulemaking; and providing for effective dates.

From the enrolled text, February 27, 2026:

AN ACT relating to public health and safety; authorizing the administration of epinephrine through the use of autoinjectors, nasal sprays and any other federally approved device or method; amending definitions; requiring rulemaking; and providing for effective dates. Section 1. W.S. 21-4-310(c)(iii), 21-4-316(a), (b)(intro), (c)(i) through (iii), (vii), (viii), (d)(intro), (ii), (e)(i), (ii), (iv) and (v), 33-24-158(b), 35-4-902(a)(viii), 35-4-903(a)(intro), (b)(intro) and (ii), 35-4-904(a), (b)(intro) and (c), 35-4-905 and 35-4-906(a) through (e) are amended to read: 21-4-310. Self-administration of medication for potentially life threatening conditions. (c) As used in this section: (iii) "Medication required for potentially life threatening conditions" includes, but is not limited to asthma medication and prescription single dose epinephrine. pens. 21-4-316. Administration of stock epinephrine. (a) A district board may adopt and implement a policy whereby the district may acquire, maintain and dispense to schools within the district a supply of epinephrine. auto-injectors. Upon authorization by the board, school nurses and assigned school personnel may administer a stock epinephrine auto-injector to a student that the school nurse or assigned school personnel in good faith believes is experiencing a severe allergic reaction. A district ORIGINAL SENATE FILE NO. SF0019 ENROLLED ACT NO. 20, SENATE SIXTY-EIGHTH LEGISLATURE OF THE STATE OF WYOMING 2026 BUDGET SESSION board shall not be required to obtain a prescription to acquire, maintain or dispense to schools …

Read the full official text

Sponsors

• Kenneth Clouston (R, H32)
• Joel Guggenmos (R, H55)
• Michael Yin (D, H16)
• Evie Brennan (R, S31)
• Chris Rothfuss (D, S09) · primary sponsor
• Schuler, Wendy (R, S15)

Latest actions

1. March 3, 2026: Assigned Chapter Number 24
2. March 3, 2026: Governor Signed SEA No. 0020
3. March 2, 2026: H Speaker Signed SEA No. 0020
4. March 2, 2026: S President Signed SEA No. 0020
5. February 27, 2026: Assigned Number SEA No. 0020
6. February 27, 2026: H 3rd Reading:Passed 59-0-3-0-0
7. February 26, 2026: H 2nd Reading:Passed
8. February 25, 2026: H COW:Passed
9. February 25, 2026: H Placed on General File
10. February 25, 2026: H10 - Labor:Recommend Do Pass 9-0-0-0-0

Votes

• H 3rd Reading:Passed 59-0-3-0-0 (February 27, 2026): 59 yea, 0 nay, passed
• H10 - Labor:Recommend Do Pass 9-0-0-0-0 (February 25, 2026): 9 yea, 0 nay, passed
• S 3rd Reading:Passed 31-0-0-0-0 (February 19, 2026): 31 yea, 0 nay, passed
• S10 - Labor:Recommend Do Pass 5-0-0-0-0 (February 16, 2026): 5 yea, 0 nay, passed
• S Introduced and Referred to S10 - Labor 29-1-1-0-0 (February 10, 2026): 29 yea, 1 nay, passed

Common questions

What is SF19?

SF19 is a bill in the Wyoming Legislature (2026 Budget Session): Epinephrine delivery methods.

What does SF19 do?

In its own words: An act relating to public health and safety; authorizing the administration of epinephrine through the use of autoinjectors, nasal sprays and any other federally approved device or method; amending definitions; requiring rulemaking; and providing for effective dates.

What is the status of SF19?

Signed into law as of March 3, 2026. Latest action: Assigned Chapter Number 24 (March 3, 2026).

Who sponsored SF19?

Chris Rothfuss (D, S09), with 5 co-sponsors.

Where is the official record for SF19?

On the Wyoming Legislature website: https://wyoleg.gov/Legislation/2026/SF0019